SCHEMBL10106235

SCHEMBL10106235

[C-]#[N+]c1ccc(Nc2ncnc(OC3CC4CCC(C3)N4S(=O)(=O)OC(C)C)c2F)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 20/20 0.55
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12277072 0.88 GPR119 (0.60) GPR119
SCHEMBL10120892 0.86 GPR119 (0.73) GPR119
SCHEMBL12277313 0.85 GPR119 (0.49) GPR119
SCHEMBL12277155 0.85 GPR119 (0.76) GPR119CYP2C9
SCHEMBL12275710 0.80 GPR119 (0.74) GPR119
SCHEMBL10106232 0.80 GPR119 (0.62) GPR119
SCHEMBL10106239 0.79 GPR119 (0.76) GPR119
SCHEMBL12277303 0.79 GPR119 (0.56) GPR119
SCHEMBL10106231 0.78 GPR119 (0.46) GPR119
SCHEMBL12276554 0.77 GPR119 (0.66) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040975-A1 BRIDGED BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF MERCK SHARP & DOHME CORP. 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040975-A1 BRIDGED BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF GPR119, BDKRB2, GLP1R GPR119 1/4885CYP2C9 999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.